Terumo Foundation for Life Sciences and Arts

HOME > Terumo Global Science Prize > Awardees > About the 2nd Awardee

About the 2nd Awardee

The winner of the 2nd Terumo Global Science Prize is Dr. Sung Wan Kim, Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry and Distinguished Professor of Bioengineering, University of Utah. Dr.Kim’s career and achievements are described below.

Dr. Sung Wan Kim
Date of Birth August 21, 1940

Career

1963 B.S., Chemistry, Seoul National University, Korea
1965 M.S., Physical Chemistry, Seoul National University, Korea
1969 Ph.D., Chemistry, University of Utah, Thesis Supervisor, Professor Henry Eyring
1971 Postdoctoral, Biomaterials - Institute for Biomedical Engineering and Department of Materials Science, University of Utah
1969 - 1971 Research Associate, Department of Materials Science and Engineering and Institute for Biomedical Engineering, University of Utah
1971 - 1977 Assistant Research Professor, Department of Materials Science and Engineering, University of Utah
1974 - 1977 Assistant Professor, Department of Applied Pharmaceutical Sciences, University of Utah
1977 - 1980 Associate Professor, Department of Pharmaceutics and Adjunct Associate Professor, Department of Bioengineering, University of Utah
1986 - 2006 Director, Center for Controlled Chemical Delivery, University of Utah
1980 - 2000 Professor, Department of Pharmaceutics and Pharmaceutical Chemistry, Adjunct Professor, Department of Bioengineering, University of Utah
2000 - present Distinguished Professor, Department of Pharmaceutics and Pharmaceutical Chemistry
2002 - present Distinguished Professor, Department of Bioengineering.

Dr. Sung Wan Kim is currently a Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry, and Bioengineering at the University of Utah. He is one of the pioneers in the areas of hydrogels, biodegradable drug conjugates, self-regulating drug delivery and stimuli sensitive polymers. He has published over 500 papers, received 35 U.S. Patents and trained over 130 scientists. He has been elected as the member of the Institute of Medicine of the National Academies (1999) and the National Academy of Engineering (2003). He had also served as a member of Gene and Drug Delivery Study Section at the National Institutes of Health (2006-2010).

Prize Records

1988 The Clemson Basic Biomaterials Award
1995 The Controlled Release Society (CRS) Founders Award
1998 American Association of Pharmaceutical Scientists (AAPS) Dale Wurster Award
1999 Elected Member in the Institute of Medicine of the National Academy of Sciences, USA
2002 AACP Volwiler Award
2003 Elected Member to the National Academy of Engineering, USA Rosenblatt Prize
Ho-Am Prize
2004 Research Achievement Award, Pharmaceutical Sciences World Congress
2006 Received Honorary Doctor of Science, University of Twente, The Netherland

Achievements and the Reasons for Prize Winning

A pioneer in the fields of biomaterials and drug delivery, Distinguished Professor Sung Wan Kim is a researcher who consistently garners cutting-edge results.
Dr. Kim worked with Dr. Willem Kolff, a University of Utah School of Medicine professor known for his research on the artificial heart, to develop the world’s first antithrombotic materials with immobilized heparin, a polysaccharide that acts as an anticoagulant. This breakthrough opened up new possibilities for hybrid biomaterials combining natural and synthetic polymers.
Applying the same concept to the field of drug delivery, Dr. Kim successfully developed the world’s first self-regulating insulin delivery system utilizing lectin specifically bound with glucose.
This intelligent drug delivery system with the ability to self-regulate required no external energy supply, an extraordinary breakthrough that dramatically improved subsequent drug delivery systems.
In the late 1990s, Dr. Kim embarked on research into polymeric gene hybridized artificial viruses.
The idea of wrapping genes in safe, avirulent polymers resolved the issue of immunoreaction posed by conventional viruses. With this groundbreaking research, Dr. Kim has been successful in delivering therapeutic genes to work on targeted areas inside the biological object.
The hybrid biomaterials and polymeric gene hybrid systems developed by Dr. Kim clearly demonstrate outstanding results from gene therapy not only in treating cancer and diabetes, but also in the field of regenerative medicine.
In this respect, Dr. Kim’s research offers extraordinarily compelling results that link biomaterials, tissue engineering, and regenerative medicine.
Dr. Kim has also become a driving force in the field of biomaterials by dedicating his time to instructing many young researchers.
For these reasons, Professor Sung Wan Kim was chosen to receive the Second Terumo Global Science Prize.

pagetop